Retroviral matrix proteins: A structural perspective

Virology

Volumn 246, Issue 2, 1998, Pages 191-198

  Conte, Maria R ^a   Matthews, Stephen ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN STRUCTURE; PROTEIN TRANSPORT; RETROVIRUS; SHORT SURVEY; VIRUS ASSEMBLY; VIRUS CELL INTERACTION;

UNIDENTIFIED RETROVIRUS;

EID: 0032486598     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9206     Document Type: Article

References (92)

1. Brody B. A., Rhee S. S., Sommerfelt M. A., Hunter E. A viral protease-mediated cleavage of the transmembrane glycoprotein of Mason-Pfizer monkey virus can be suppressed by mutations within the matrix protein. Proc. Natl. Acad. Sci. USA. 89:1992;3443-3447.
2. Bryant M., Ratner L. Myristoylation-dependent replication and assembly of human immunodeficiency virus 1. Proc. Natl. Acad. Sci. USA. 87:1990;523-527.
3. Bukrinskaya A. G., Ghorpade A., Heinzinger N. K., Smithgall T. E., Lewis R. E., Stevenson M. Phosphorylation-dependent human immunodeficiency virus type 1 infection and nuclear targeting of viral DNA. Proc. Natl. Acad. Sci. USA. 93:1996;367-371.
4. Bukrinsky M. I., Haggerty S., Dempsey M. P., Sharova N., Adzhubei A., Spitz L., Lewis P., Goldfarb D., Emerman M., Stevenson M. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature. 365:1993;666-669.
5. Bukrinsky M. I., Sharova N., Dempsey M. P., Stanwick T. L., Bukrinskaya A. G., Haggerty S., Stevenson M. Active nuclear import of human immunodeficiency virus type 1 preintegration complex. Proc. Natl. Acad. Sci. USA. 89:1992;6580-6584.
6. Cannon P. M., Matthews S., Clark N., Byles E. D., Iourin O., Hockley D. J., Kingsman S. M., Kingsman A. J. Structure-function studies of the human immunodeficiency virus type 1 matrix protein, p17. J. Virol. 71:1997;3474-3483.
7. Christensen A. M., Massiah M. A., Turner B., Sundquist W. I., Summers M. F. Three-dimensional structure of the HTLV-II matrix protein and comparative analysis of matrix proteins from different classes of pathogenic human retroviruses. J. Mol. Biol. 264:1996;1117-1131.
8. Conte M. R., Klikova M., Hunter E., Ruml T., Matthews S. The three-dimensional solution structure of the matrix protein from the type D retrovirus, the Mason-Pfizer monkey virus, and implications for the morphology of retroviral assembly. EMBO J. 16:1997;5819-5826.
9. Cosson P. Direct interaction between the envelope and matrix proteins of HIV-1. EMBO J. 15:1996;5783-5788.
10. Dorfman T., Bukovsky A., Ohagen A., Hoglund S., Gottlinger H. G. Functional domains of the capsid protein of human immunodeficiency virus type 1. J. Virol. 68:1994a;8180-8187.
11. Dorfman T., Mammano F., Haseltine W. A., Gottlinger H. G. Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein. J. Virol. 68:1994b;1689-1696.
12. Dubay J. W., Roberts S. J., Hahn B. H., Hunter E. Truncation of the human immunodeficiency virus type 1 transmembrane glycoprotein cytoplasmic tail blocks virus infectivity. J. Virol. 66:1992;6616-6625.
13. Facke M., Janetzko A., Shoeman R. L., Krausslich H.-G. A large deletion in the matrix protein of the human immunodeficiency virusgag. J. Virol. 67:1993;4972-4980.
14. Fouchier R. A. M., Meyer B. E., Simon J. H. M., Fisher U., Malim M. H. HIV-1 infection of non-dividing cells: Evidence that the amino-terminal basic region of the viral matrix protein is important for Gag processing but not for post-entry nuclear import. EMBO J. 16:1997;4531-4539.
15. Freed E. O., Englund G., Maldarelli F., Martin M. A. Phosphorylation of residue 131 of HIV-1 matrix is not required for macrophage infection. Cell. 88:1997;171-173.
16. Freed E. O., Martin M. A. Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tail is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix. J. Virol. 69:1995;1984-1989.
17. Freed E. O., Martin M. A. Domains of the immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions. J. Virol. 70:1996;341-351.
18. Freed E. O., Orestein J. M., Buckler-White A. J., Martin M. A. Single amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle production. J. Virol. 68:1994;5311-5320.
19. Fuller S. D., Wilk T., Gowen B. E., Krausslick H.-G., Vogt V. M. Cryo-electron microscopy reveals ordered domains in the immature HIV-1 particle. Curr. Biol. 7:1997;729-738.
20. Gabuzda D. H., Lever A., Terwillinger E., Sodroski J. Effects of deletions in the cytoplasmic domain on biological functions of human immunodeficiency virus type 1 envelope glycoproteins. J. Virol. 66:1992;3306-3315.
21. Gallay P., Hope T., Chin D., Trono D. HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway. Proc. Natl. Acad. Sci. USA. 94:1997;9825-9830.
22. Gallay P., Swingler S., Aiken C., Trono D. HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is key regulator. Cell. 80:1995a;379-388.
23. Gallay P., Swingler S., Song J., Bushman F., Trono D. HIV-1 nuclear import is governed by the phosphotyrosine-mediated binding of matrix to core domain of integrase. Cell. 83:1995b;569-576.
24. Gamble T. R., Yoo S., Vajdos F. F., von Schwedler U. K., Worthylake D. K., Wang H., McCutcheon J. P., Sundquist W. I., Hill C. P. Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein. Science. 278:1997;849-852.
25. Gebhardt A., Bosch J. V., Ziemiecki A., Friis R. R. Rous sarcoma virus p19 and gp35 can be chemically crosslinked to high molecular weight complexes. J. Mol. Biol. 174:1984;297-317.
26. Gelderblom H. R., Hausmann E. H. S., Ozel M., Pauli G., Koch M. A. Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins. Virology. 156:1987;171-176.
27. Gelderblom H. R., Ozel M., Pauli G. Morphogenesis and morphology of HIV. Structure-function relations. Arch. Virol. 106:1989;1-13.
28. Gonzalez S. A., Affranchino J. L., Gelderblom H. R., Burny A. Assembly of matrix protein of simian immunodeficiency virus into virus-like particles. Virology. 194:1993;548-556.
29. Gottlinger H. G., Dorfman T., Sodroski J. G., Haseltine W. A. Effects of mutations affecting the p6 Gag protein of human immunodeficiency virus particle release. Proc. Natl. Acad. Sci. USA. 88:1991;3195-3199.
30. Heinzinger N. K., Bukrinsky M. I., Haggerty S. A., Ragland A. M., Kewalramani V., Lee M.-A., Gendelman H. E., Ratner L., Stevenson M., Emerman M. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc. Natl. Acad. Sci. USA. 91:1994;7311-7315.
31. Henderson L. E., Sowder R. C., Smythers G. W., Oroszlan S. Chemical and immunological characterizations of equine infectious anemia virusgag. J. Virol. 61:1987;1116-1124.
32. Hill C. P., Worthylake D., Bancroft D. P., Christensen A. M., Sundquist W. I. Crystal structure of the trimeric human immunodeficiency virus type 1 matrix protein: Implications for membrane association and assembly. Proc. Natl. Acad. Sci. USA. 93:1996;3099-3104.
33. Humphries E. H., Temin H. M. Cell cycle dependent activation of Rous sarcoma virus-infected stationary chicken cells: Avian leukosis virus group-specific antigen and ribonucleic acid. J. Virol. 10:1972;82-87.
34. Humphries E. H., Temin H. M. Requirement for cell division for initiation of transcription of Rous sarcoma virus RNA. J. Virol. 14:1974;531-546.
35. Hunter E. Macromolecular interactions in the assembly of HIV and other retroviruses. Semin. Virol. 5:1994;71-83.
36. Hunter E., Hill E., Hardwick J. M., Bhown A., Schwartz D. E., Tizard R. Complete sequence of Rous sarcoma virusenv. J. Virol. 46:1983;920-936.
37. Johnston P., Dubay J., Hunter E. Truncations of SIV transmembrane protein confer expanded virus host range by removing a block to virus entry into cells. J. Virol. 67:1993;3077-3086.
38. gagmyristylation and virus replication. J. Virol. 62:1988;3217-3223.
39. Jorgensen E. C., Pedersen F. S., Jorgensen P. Matrix protein of Akv murine leukemia virus: Genetic mapping of region essential for particle formation. J. Virol. 66:1992;4479-4487.
40. Kraulis P. J. Molscript - A program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24:1991;946-950.
41. Landau N. R., Littman D. R. Packaging system for rapid production of murine leukemia virus vectors with variable tropism. J. Virol. 66:1992;5110-5113.
42. Lenard J. Negative-strand virus M and retrovirus MA proteins: all in a family. Virology. 216:1996;289-298.
43. Lewis P. F., Emerman M. Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J. Virol. 68:1994;510-516.
44. Lewis P., Hensel M., Emerman M. Human immunodeficiency virus infection of cells arrested in the cell cycle. EMBO J. 11:1992;3053-3058.
45. Lusso P., Lori F., Gallo R. C. CD4 independent infection by immunodeficiency virus type 1 after phenotypic mixing with human T-cell leukemia viruses. J. Virol. 64:1990a;6341-6344.
46. Lusso P., Veronese F. D., Ensoli B., Franchini G., Jemma C., Derocco S. E., Kalyanaraman V. S., Gallo R. C. Expanded HIV-1 cellular tropism by phenotypic mixing with murine endogenous retroviruses. Science. 247:1990b;848-852.
47. Mammano F., Kondo E., Sodroski J., Bukovsky A., Gottlinger H. G. Rescue of human immunodeficiency virus type 1 matrix protein mutants by envelope glycoproteins with short cytoplasmic domains. J. Virol. 69:1995;3824-3830.
48. +. J. Virol. 71:1997;3341-3345.
49. Massiah M. A., Staricg M. R., Paschall C., Summers M. F., Christensen A. M., Sundquist W. I. The three-dimensional structure of the human immunodeficiency virus type I matrix protein. J. Mol. Biol. 244:1994;198-223.
50. Matthews S., Barlow P., Boyd J., Barton G., Russell R., Mills H., Cunningham M., Meyers N., Burns N., Clark N., Kingsman S., Kingsman A., Campbell I. Structural similarity between the p17 matrix protein of HIV-1 and interferon-γ Nature. 370:1994;666-668.
51. Matthews S., Barlow P., Clark N., Kingsman S., Kingsman A., Campbell I. The refined solution structure of the HIV-1 matrix protein, p17. Biochem. Soc. Trans. 23:1995;725-728.
52. Matthews S., Mikhailov M., Burny A., Roy P. The solution structure of the bovine leukemia virus matrix protein and similarity with lentiviral matrix proteins. EMBO J. 15:1996;3267-3274.
53. McDonnell J. M., Fushman D., Cahill S. M., Zhou W., Wolven A., Wilson C. B., Nelle T. D., Resh M. D., Wills J., Cowburn D. Solution structure and dynamics of the bioactive retroviral M domain from Rous sarcoma virus. J. Mol. Biol. 1998.
54. Mergener K., Facke M., Welker R., Brinkmann V., Gelderblom H. R., Krausslich H.-G. Analysis of HIV particle formation using transient expression of subviral construct in mammalian cells. Virology. 186:1992;25-39.
55. Momany C., Kovari L. C., Prongay A. J., Keller W., Gitti R. K., Lee B. M., Gorbalenya A. E., Tong L., McClure J., Ehrlich L. S., Summers M. F., Carter C., Rossman M. G. Crystal structure of dimeric HIV-1 capsid protein. Nature Struct. Biol. 3:1996;763-770.
56. Morikawa Y., Kishi T., Zhang W. H., Nermut M. V., Hockley D. J., Jones I. M. A molecular determinant of human immunodeficiency virus particle assembly located in the matrix antigen p17. J. Virol. 69:1995;4519-4523.
57. Myers G., Wain-Hobson S., Korber B., Smith R. F., Pavlakis G. N. Human Retroviruses and AIDS: A Compilation and Analysis of Nucleic Acids and Amino Acid Sequences. ed. 1993;Los Alamos Nat. Laboratory, Los Alamos.
58. Nelle T. D., Wills J. W. A large region within the Rous sarcoma virus matrix protein is dispensable for budding and infectivity. J. Virol. 70:1996;2269-2276.
59. Nermut M. V., Hockley D. J., Jowett J. B. M., Jones I. M., Garreau M., Thomas D. Fullerene-like organization of HIV Gag-protein shell in virus-like particles produced by recombinant baculoviruses. Virology. 198:1994;288-296.
60. Ono A., Huang M., Freed E. O. Characterization of human immunodeficiency virus type 1 matrix revertants: Effects on virus assembly, Gag processing, and Env incorporation into virions. J. Virol. 71:1997;4409-4418.
61. gag). Virology. 91:1978;423-433.
62. Perez L. G., Davis G. L., Hunter E. Mutants of the Rous sarcoma virus envelope glycoprotein that lack of the transmembrane anchor and cytoplasmic domains: Analysis of intracellular transport and assembly into virions. J. Virol. 61:1987;2981-2988.
63. Pinter A., Honnen W. J. Topography of murine leukemia virus envelope proteins: characterization of transmembrane components. J. Virol. 46:1983;1056-1060.
64. Ragheb J. A., Anderson W. F. Uncoupled expression of Moloney murine leukemia virus envelope polypeptides SU and TM: A functional analysis of the role of TM domains in viral entry. J. Virol. 68:1994;3207-3219.
65. Rao Z. H., Beyaev A. S., Fry E., Roy P., Jones I. M., Stuart D. I. Crystal structure of SIV matrix antigen and its implications for virus assembly. Nature. 378:1995;743-747.
66. Rhee S. R., Hunter E. Myristylation is required for intracellular transport but not for assembly of D-type retrovirus capsids. J. Virol. 61:1987;1045-1053.
67. Rhee S. R., Hunter E. A single amino acid substitution within the matrix protein of a type D retrovirus converts its morphogenesis to that of a type C retrovirus. Cell. 63:1990;77-86.
68. Rhee S. R., Hunter E. Amino acid substitutions within the matrix protein of type D retroviruses affect assembly, transport and membrane association of a capsid. EMBO J. 10:1991;535-546.
69. Rice N. R., Henderson L. E., Sowder R. C., Copeland T. D., Oroszlan S., Edwards J. F. Synthesis and processing of the transmembrane envelope protein of equine infectious anemia virus. J. Virol. 64:1990;3770-3778.
70. gagis excluded from virus assembly and maturation events. J. Virol. 63:1989;2370-2373.
71. Sha B., Luo M. Structure of a bifunctional membrane-RNA binding protein, influenza virus matrix protein M1. Nature Struct. Biol. 4:1997;239-244.
72. Soneoka Y., Kingsman S. M., Kingsman A. J. Mutagenesis analysis of murine leukemia virus matrix protein: Identification of regions important for membrane localization and intracellular transport. J. Virol. 71:1997;5549-5559.
73. Sonigo P., Barker C., Hunter E., Wain-Hobson S. Nucleotide sequence of Mason-Pfizer monkey virus: An immunosuppressive D-type retrovirus. Cell. 45:1986;375-385.
74. Spearman P., Horton R., Ratner L., Kuli-Zade I. Membrane binding of human immunodeficiency virus type 1 matrix protein in vivo supports a conformational myristyl switch mechanism. J. Virol. 71:1997;6582-6592.
75. Spector D. H., Wade E., Wright D. A., Koval V., Clark C., Jaquish D., Spector S. A. Human immunodeficiency virus pseudotypes with expanded cellular and species tropism. J. Virol. 64:1990;2298-2308.
76. Towler D. A., Gordon J. I., Adams S. P., Glaser L. The biology and enzymology of eukaryotic protein acylation. Annu. Rev. Biochem. 57:1988;69-99.
77. Trono D., Gallay P. Phosphorylation of residue 131 of HIV-1 matrix is not required for macrophage infection- response. Cell. 88:1997;173-174.
78. Verderame M. F., Nelle T. D., Wills J. W. The membrane-binding domain of the Rous sarcoma virus Gag protein. J. Virol. 70:1996;2664-2668.
79. Vile R. G., Schulz T. F., Danos O. F., Collins M. K. L., Weiss R. A. A murine cell line producing HTLV-1 pseudotype virions carrying a selectable marker gene. Virology. 180:1991;420-424.
80. von Schwedler U., Kornbluth R. S., Trono D. The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infectionin macrophages and quiescent T lymphocytes. Proc. Natl. Acad. Sci. USA. 91:1994;6992-6996.
81. Weinberg J. B., Matthews T. J., Cullen B. R., Malim M. H. Productive human immunodeficiency virus type 1 (HIV-1) infection of nonproliferating human monocytes. J. Exp. Med. 174:1991;1477-1482.
82. Wilk T., Pfeiffer T., Bosch V. Retained in vitro infectivity and cytopathogenicity of HIV-1 despite truncation of the C-terminal tail of the env gene product. Virology. 189:1992;167-177.
83. Wills J. W., Craven R. C. Form, function and use of retroviral Gag proteins. AIDS. 5:1991;639-654.
84. syc. J. Virol. 65:1991;3804-3812.
85. Wilson C., Reitz M. S., Okayama H., Eiden M. V. Formation of infectious hybrid virions with gibbon ape leukemia virus and human T-cell leukemia virus retroviral envelope glycoproteins and thegagpol. J. Virol. 63:1989;2374-2378.
86. Yu X., Yuan X., Matzuda Z., Lee T.-H., Essex M. The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein in mature virions. J. Virol. 66:1992;4966-4971.
87. Yu X. F., Yuan X., McLane M. F., Lee T.-H., Essex M. Mutations in the cytoplasmic domain of human immunodeficiency virus type 1 transmembrane protein impair the incorporation of Env proteins into mature virions. J. Virol. 67:1993;213-221.
88. Yuan Y., Yu X. F., Lee T.-H., Essex M. Mutations in the N terminal region of human immunodeficiency virus type 1 matrix protein block intracellular transport of the Gag precursor. J. Virol. 67:1993;6387-6394.
89. Young J. A. T., Bates P., Willert K., Varmus H. E. Efficient incorporation of human CD4 protein into avian leukosis virus particles. Science. 250:1990;1421-1423.
90. Zhou W., Parent L. J., Wills J. W., Resh M. D. Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids. J. Virol. 68:1994;2556-2569.
91. Zhou W., Resh M. D. Differential membrane binding of the human immunodeficiency virus type 1 matrix protein. J. Virol. 70:1996;8540-8548.
92. Zingler K., Littman D. Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein increases Env incorporation into particles and fusogenicity and infectivity. J. Virol. 67:1993;2824-2831.